Literature DB >> 25031344

Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.

Fatma Berri1, Ghina Haffar1, Vuong Ba Lê1, Anne Sadewasser2, Katharina Paki2, Bruno Lina1, Thorsten Wolff2, Béatrice Riteau3.   

Abstract

UNLABELLED: During the budding process, influenza A viruses (IAVs) incorporate multiple host cell membrane proteins. However, for most of them, their significance in viral morphogenesis and infectivity remains unknown. We demonstrate here that the expression of annexin V (A5) is upregulated at the cell surface upon IAV infection and that a substantial proportion of the protein is present in lipid rafts, the site of virus budding. Western blotting and immunogold analysis of highly purified IAV particles showed the presence of A5 in the virion. Significantly, gamma interferon (IFN-γ)-induced Stat phosphorylation and IFN-γ-induced 10-kDa protein (IP-10) production in macrophage-derived THP-1 cells was inhibited by purified IAV particles. Disruption of the IFN-γ signaling pathway was A5 dependent since downregulation of its expression or its blockage reversed the inhibition and resulted in decreased viral replication in vitro. The functional significance of these results was also observed in vivo. Thus, IAVs can subvert the IFN-γ antiviral immune response by incorporating A5 into their envelope during the budding process. IMPORTANCE: Many enveloped viruses, including influenza A viruses, bud from the plasma membrane of their host cells and incorporate cellular surface proteins into viral particles. However, for the vast majority of these proteins, only the observation of their incorporation has been reported. We demonstrate here that the host protein annexin V is specifically incorporated into influenza virus particles during the budding process. Importantly, we showed that packaged annexin V counteracted the antiviral activity of gamma interferon in vitro and in vivo. Thus, these results showed that annexin V incorporated in the viral envelope of influenza viruses allow viral escape from immune surveillance. Understanding the role of host incorporated protein into virions may reveal how enveloped RNA viruses hijack the host cell machinery for their own purposes.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25031344      PMCID: PMC4178827          DOI: 10.1128/JVI.01405-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Pathogenesis of influenza virus infections: the good, the bad and the ugly.

Authors:  T Kuiken; B Riteau; R A M Fouchier; G F Rimmelzwaan
Journal:  Curr Opin Virol       Date:  2012-03-15       Impact factor: 7.090

Review 2.  The change of cellular membranes on apoptosis: fluorescence detection.

Authors:  A P Demchenko
Journal:  Exp Oncol       Date:  2012-10

3.  Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo.

Authors:  Xiaocai Yan; Kara Doffek; Chaobo Yin; Michael Krein; Michael Phillips; Sonia L Sugg; Bryon Johnson; Joel Shilyansky
Journal:  Cancer Immunol Immunother       Date:  2012-04-05       Impact factor: 6.968

4.  Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Authors:  Nicole Gudleski-O'Regan; Todd M Greco; Ileana M Cristea; Thomas Shenk
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 5.  Role for proteases and HLA-G in the pathogenicity of influenza A viruses.

Authors:  Marie-Laure Foucault; Vincent Moules; Manuel Rosa-Calatrava; Béatrice Riteau
Journal:  J Clin Virol       Date:  2011-05-25       Impact factor: 3.168

6.  Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

Authors:  Wendy C L Yu; Renee W Y Chan; Jieru Wang; Emily A Travanty; John M Nicholls; J S Malik Peiris; Robert J Mason; Michael C W Chan
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 7.  Induction and evasion of type I interferon responses by influenza viruses.

Authors:  Adolfo García-Sastre
Journal:  Virus Res       Date:  2011-10-21       Impact factor: 3.303

8.  HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.

Authors:  Sonia Zilberman; Chantal Schenowitz; Sophie Agaugué; Favier Benoît; Béatrice Riteau; Roman Rouzier; Edgardo D Carosella; Nathalie Rouas-Freiss; Catherine Menier
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

9.  PAR1 contributes to influenza A virus pathogenicity in mice.

Authors:  Khaled Khoufache; Fatma Berri; Wolfgang Nacken; Annette B Vogel; Marie Delenne; Eric Camerer; Shaun R Coughlin; Peter Carmeliet; Bruno Lina; Guus F Rimmelzwaan; Oliver Planz; Stephan Ludwig; Béatrice Riteau
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 10.  CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.

Authors:  Mingli Liu; Shanchun Guo; Jacqueline M Hibbert; Vidhan Jain; Neeru Singh; Nana O Wilson; Jonathan K Stiles
Journal:  Cytokine Growth Factor Rev       Date:  2011-07-29       Impact factor: 7.638

View more
  8 in total

1.  Infectious Salmon Anaemia Virus (ISAV) RNA Binding Protein Encoded by Segment 8 ORF2 and Its Interaction with ISAV and Intracellular Proteins.

Authors:  Christel M Olsen; Turhan Markussen; Bernd Thiede; Espen Rimstad
Journal:  Viruses       Date:  2016-02-18       Impact factor: 5.048

Review 2.  FPR2: A Novel Promising Target for the Treatment of Influenza.

Authors:  Marie-Christine Alessi; Nicolas Cenac; Mustapha Si-Tahar; Béatrice Riteau
Journal:  Front Microbiol       Date:  2017-09-05       Impact factor: 5.640

3.  Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production.

Authors:  Yanni Gao; Yao Zhang; Yongxiu Yao; Xiaolu Guan; Yongzhen Liu; Xiaole Qi; Yongqiang Wang; Changjun Liu; Yanping Zhang; Honglei Gao; Venugopal Nair; Xiaomei Wang; Yulong Gao
Journal:  Oncotarget       Date:  2016-12-06

4.  The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.

Authors:  Fryad Rahman; Mohammad Chebbo; Noémie Courtin; Aurelien Fotso Fotso; Marie-Christine Alessi; Béatrice Riteau
Journal:  Int J Mol Sci       Date:  2018-05-08       Impact factor: 5.923

Review 5.  Annexins in Translational Research: Hidden Treasures to Be Found.

Authors:  Sebastian Schloer; Denise Pajonczyk; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2018-06-15       Impact factor: 5.923

Review 6.  Annexins in Influenza Virus Replication and Pathogenesis.

Authors:  Patrick Baah Ampomah; Wan Ting Kong; Olga Zharkova; Sonja C J H Chua; R Perumal Samy; Lina H K Lim
Journal:  Front Pharmacol       Date:  2018-11-15       Impact factor: 5.810

7.  Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

Authors:  Huriye Ercan; Waltraud Cornelia Schrottmaier; Anita Pirabe; Anna Schmuckenschlager; David Pereyra; Jonas Santol; Erich Pawelka; Marianna T Traugott; Christian Schörgenhofer; Tamara Seitz; Mario Karolyi; Jae-Won Yang; Bernd Jilma; Alexander Zoufaly; Alice Assinger; Maria Zellner
Journal:  Front Cardiovasc Med       Date:  2021-11-11

8.  Interferon-gamma inhibits influenza A virus cellular attachment by reducing sialic acid cluster size.

Authors:  Carol Ho-Yan Fong; Lu Lu; Lin-Lei Chen; Man-Lung Yeung; Anna Jinxia Zhang; Hanjun Zhao; Kwok-Yung Yuen; Kelvin Kai-Wang To
Journal:  iScience       Date:  2022-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.